As a follow-up, a study was conducted to investigate the blood DNA methylation status of MCP-1 promoter CpG sites and their association with serum MCP-1 and blood glucose levels in patients with T2DM and healthy (control) individuals. This evidence concerns the gene CCL2 and type 2 diabetes mellitus.